RBM4 and renal carcinoma: Next, we conducted CD8+ T cell-mediated killing experiments and found that when RBM4 was knocked down, CD8+ T cell-mediated renal cancer cell death increased, while when RBM4 was overexpressed, CD8+ T cell-mediated renal cancer cell death decreased (Figure 5B-C, S5K-L).